INNV has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
INNV has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. InnovAge Holding's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 93.75%.
InnovAge Holding's EBITDA per Share for the three months ended in Mar. 2024 was $-0.00.
The historical data trend for InnovAge Holding's YoY EBITDA Growth can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InnovAge Holding Annual Data | |||||||||||
Trend | Jun19 | Jun20 | Jun21 | Jun22 | Jun23 | ||||||
YoY EBITDA Growth | - | 56.55 | -110.57 | 241.67 | -467.65 |
InnovAge Holding Quarterly Data | |||||||||||||||||||
Jun19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
YoY EBITDA Growth | Get a 7-Day Free Trial | -60.00 | 21.54 | 55.67 | 115.49 | 93.75 |
YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.
InnovAge Holding's YoY EBITDA Growth for the fiscal year that ended in Jun. 2023 is calculated as:
YoY EBITDA Growth (A: Jun. 2023 ) | |||||
= | (EBITDA per Share (A: Jun. 2023 ) | - | EBITDA per Share (A: Jun. 2022 )) | / | | EBITDA per Share (A: Jun. 2022 ) | |
= | (-0.25 | - | 0.068) | / | | 0.068 | |
= | -467.65 % |
InnovAge Holding's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:
YoY EBITDA Growth (Q: Mar. 2024 ) | |||||
= | (EBITDA per Share (Q: Mar. 2024 ) | - | EBITDA per Share (Q: Mar. 2023 )) | / | | EBITDA per Share (Q: Mar. 2023 )) | |
= | (-0.002 | - | -0.032) | / | | -0.032 | |
= | 93.75 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of InnovAge Holding's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.
Teresa Sparks | director | 40 BURTON HILLS BOULEVARD SUITE 500, NASHVILLE TN 37215 |
Nicole Damato | officer: CHIEF LEGAL OFFICER | 8950 E. LOWRY BOULEVARD, DENVER CO 80230 |
Benjamin C Adams | officer: CHIEF FINANCIAL OFFICER | 8950 E. LOWRY BOULEVARD, DENVER CO 80230 |
Patricia Fontneau | director | 8950 E. LOWRY BOULEVARD, DENVER CO 80230 |
Christine Bent | officer: CHIEF OPERATIONS OFFICER | 8950 E. LOWRY BOULEVARD, DENVER CO 80230 |
Thomas Scully | director | 320 PARK AVENUE, SUITE # 2500, NEW YORK NM 10022 |
Richard Feifer | officer: CHIEF MEDICAL OFFICER | C/O GENESIS HEALTHCARE, INC., 101 EAST STATE STREET, KENNETT SQUARE PA 19348 |
James G Carlson | director | 8950 E. LOWRY BOULEVARD, DENVER CO 80230 |
Patrick T Blair | officer: PRESIDENT | 8950 E. LOWRY BOULEVARD, DENVER CO 80230 |
Caroline Dechert | director | 580 CALIFORNIA ST., SUITE 1700, SAN FRANCISCO CA 94104 |
Pavithra Mahesh | director | 601 LEXINGTON AVE., 53RD FLOOR, NEW YORK NY 10022 |
Maureen Hewitt | director, officer: CEO, President and Director | 8950 E. LOWRY BLVD., DENVER CO 80230 |
Maria Lozzano | officer: CORPORATE COO | 8950 E. LOWRY BLVD., DENVER CO 80230 |
Robin Doerr | officer: CHIEF SALES AND MKTG. OFFICER | 8950 E. LOWRY BLVD., DENVER CO 80230 |
Melissa Welch | officer: CHIEF MEDICAL OFFICER | 8950 E. LOWRY BLVD., DENVER CO 80230 |
From GuruFocus
By Ds*** Ds*** • 09-02-2022
By sperokesalga sperokesalga • 03-01-2023
By GuruFocusNews GuruFocusNews • 07-10-2022
By Stock market mentor Stock market mentor • 01-24-2023
By GuruFocusNews GuruFocusNews • 06-30-2022
By Ds*** Ds*** • 08-29-2022
By Stock market mentor Stock market mentor • 01-05-2023
By PRNewswire PRNewswire • 06-03-2022
By Marketwired • 10-02-2023
By Marketwired • 09-12-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.